Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations
- PMID: 34274547
- PMCID: PMC8282441
- DOI: 10.1016/j.autrev.2021.102908
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations
Keywords: Mycophenolate; Vaccination SARS-CoV-2; mRNA BNT162b2.
Conflict of interest statement
M.B, M. I, M.M, F.LG, P.S.P., M.C, declare the absence of conflict of interest for this research and in the writing of the manuscript.
Comment on
-
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23. Ann Rheum Dis. 2021. PMID: 33757968 Free PMC article. No abstract available.
-
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.Ann Rheum Dis. 2021 Oct;80(10):1306-1311. doi: 10.1136/annrheumdis-2021-220272. Epub 2021 Mar 24. Ann Rheum Dis. 2021. PMID: 33762264 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous